These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 23407717)

  • 1. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased platelet reactivity identified by whole blood flow cytometry in Fanconi anaemia patients.
    Holzhauer S; Sitaru AG; Ebell W; Schindler D; Hanenberg H; Wirbelauer J; Walter U; Grossmann R
    Thromb Haemost; 2007 Dec; 98(6):1291-7. PubMed ID: 18064327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia.
    Alvarez Román MT; Fernández Bello I; Arias-Salgado EG; Rivas Pollmar MI; Jiménez Yuste V; Martín Salces M; Butta NV
    Thromb Haemost; 2014 Jul; 112(1):65-72. PubMed ID: 24500066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders.
    Connor DE; Ma DD; Joseph JE
    Thromb Res; 2013 Nov; 132(5):572-7. PubMed ID: 24094604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.
    Grünewald M; Siegemund A; Grünewald A; Konegen A; Koksch M; Griesshammer M
    Platelets; 2002 Dec; 13(8):451-8. PubMed ID: 12487778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function in the myelodysplastic syndromes.
    Mittelman M; Zeidman A
    Int J Hematol; 2000 Feb; 71(2):95-8. PubMed ID: 10745619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
    Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
    Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Involved in Maintaining Haemostasis in Patients with Myelodysplastic Syndrome.
    Fernández Bello I; Jiménez-Yuste V; de Paz R; Martín Salces M; Justo Sanz R; Monzón Manzano E; Arias-Salgado EG; Álvarez Román MT; Rivas Pollmar MI; Goyanes I; Butta NV
    Thromb Haemost; 2018 Apr; 118(4):734-744. PubMed ID: 29554698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients.
    Houwerzijl EJ; Blom NR; van der Want JJ; Louwes H; Esselink MT; Smit JW; Vellenga E; de Wolf JT
    Blood; 2005 May; 105(9):3472-9. PubMed ID: 15542580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and Norway.
    Hellström-Lindberg E; Kanter-Lewensohn L; Nichol J; Ost A
    Br J Haematol; 1999 Jun; 105(4):966-73. PubMed ID: 10554808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
    Hou M; Andersson PO; Stockelberg D; Mellqvist UH; Ridell B; Wadenvik H
    Br J Haematol; 1998 Jun; 101(3):420-4. PubMed ID: 9633881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets significantly modify procoagulant activities in haemophilia A.
    Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
    Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.
    Tamura H; Ogata K; Luo S; Nakamura K; Yokose N; Dan K; Tohyama K; Yoshida Y; Hamaguchi H; Sakamaki H; Kuwaki T; Tahara T; Kato T; Nomura T
    Br J Haematol; 1998 Dec; 103(3):778-84. PubMed ID: 9858230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective platelet aggregation in myelodysplastic syndromes.
    Girtovitis FI; Ntaios G; Papadopoulos A; Ioannidis G; Makris PE
    Acta Haematol; 2007; 118(2):117-22. PubMed ID: 17726306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant and prothrombotic effects of the herbal medicine, Dipsacus asper and its active ingredient, dipsacus saponin C, on human platelets.
    Song JS; Lim KM; Kang S; Noh JY; Kim K; Bae ON; Chung JH
    J Thromb Haemost; 2012 May; 10(5):895-906. PubMed ID: 22405282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell-derived microparticles (RMP) as haemostatic agent.
    Jy W; Johansen ME; Bidot C; Horstman LL; Ahn YS
    Thromb Haemost; 2013 Oct; 110(4):751-60. PubMed ID: 24030707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.